Cai‐Jin Lin
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Diagnosis and Treatment
Papers in
-
- Breast Cancer Treatment Studies 16
- Cancer Genomics and Diagnostics 8
- Oncology 16
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 4
Cai‐Jin Lin
33 papers receiving 327 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 132
- Oncology 152
- Otorhinolaryngology 15
- Pathology and Forensic Medicine 55
- Pulmonary and Respiratory Medicine 96
Countries citing papers authored by Cai‐Jin Lin
This map shows the geographic impact of Cai‐Jin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cai‐Jin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cai‐Jin Lin more than expected).
Fields of papers citing papers by Cai‐Jin Lin
This network shows the impact of papers produced by Cai‐Jin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cai‐Jin Lin. The network helps show where Cai‐Jin Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Cai‐Jin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 18 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 54 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 3 | |
| 17 | 2019 | 17 | |
| 18 | 2019 | 14 | |
| 19 | 2019 | 26 | |
| 20 | 2018 | 10 |
About Cai‐Jin Lin
Cai‐Jin Lin is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Hepatology, having authored 34 papers that have together received 329 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (8 papers), Advanced Breast Cancer Therapies (7 papers), Breast Lesions and Carcinomas (6 papers), Cancer Treatment and Pharmacology (4 papers), Multiple and Secondary Primary Cancers (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Cancer Research (132 citations), Oncology (152 citations), Otorhinolaryngology (15 citations), Pathology and Forensic Medicine (55 citations) and Pulmonary and Respiratory Medicine (96 citations). Cai‐Jin Lin has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Li Zhu, Jiayi Wu, Kunwei Shen, Shuning Ding, Zhi‐Ming Shao, Xi Jin, Weiguo Chen, Yi‐Zhou Jiang, Jinxiu Shi and Han Luo. Their work appears in journals such as Frontiers in Oncology, Cancer Research and Treatment, Clinical Breast Cancer, Oncotarget and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.